Hot Features
プレミアム
Alnylam Pharmace Dl 0001 (DUL)
TG
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Ms. Amy W. SchulmanIndependent Chair of the Board | 11.25k | 789.75k | Derivative Exercise and Retained Stock | 70.20 | 23.21k | 94.06% |
| 2026-04-06 | Ms. Melissa McLaughlinChief HR Officer | -2.29k | 755.33k | Automatic Disposition | 320.14 - 333.94 | 9.44k | -19.49% |
| 2026-04-02 | Ms. Melissa McLaughlinChief HR Officer | -8.00 | 2.60k | 売り | 325.49 | 9.44k | -0.08% |
| 2026-04-02 | Ms. Melissa McLaughlinChief HR Officer | -1.62k | 516.41k | 売り | 316.61 - 323.64 | 9.44k | -14.61% |
| 2026-03-04 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -4.71k | 1.52M | 売り | 319.03 - 326.08 | 16.46k | -22.26% |
| 2026-03-04 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2.47k | 797.35k | 売り | 319.03 - 325.67 | 44.44k | -5.26% |
| 2026-03-04 | Dr. Yvonne L. GreenstreetCEO & Director | -2.93k | 947.58k | 売り | 319.03 - 325.67 | 62.36k | -4.49% |
| 2026-03-04 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -633.00 | 204.51k | 売り | 319.03 - 325.67 | 14.84k | -4.09% |
| 2026-03-05 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -658.00 | 213.18k | Automatic Disposition | 321.81 - 326.24 | 14.84k | -4.25% |
| 2026-03-04 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -2.31k | 745.98k | 売り | 319.03 - 325.67 | 18.52k | -11.09% |
| 2026-03-02 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2.21k | 722.80k | 売り | 323.62 - 332.64 | 41.86k | -5.01% |
| 2026-03-02 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1.72k | 562.59k | 売り | 323.62 - 332.64 | 3.60k | -32.31% |
| 2026-03-02 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1.60k | 523.58k | 売り | 323.62 - 332.64 | 16.13k | -9.02% |
| 2026-03-03 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1.78k | 567.55k | Automatic Disposition | 316.74 - 321.50 | 3.60k | -33.04% |
| 2026-03-03 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1.65k | 528.19k | Automatic Disposition | 316.55 - 321.58 | 16.13k | -9.29% |
| 2026-03-02 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1.60k | 523.58k | 売り | 323.62 - 332.64 | 16.12k | -9.02% |
| 2026-03-02 | Dr. Yvonne L. GreenstreetCEO & Director | -6.80k | 2.23M | 売り | 323.62 - 332.64 | 59.31k | -10.28% |
| 2026-02-27 | Mr. Jeffrey V. PoultonCFO & Exec. VP | 1.91k | 0.00 | Derivative Exercise and Retained Stock | - | 41.49k | 4.82% |
| 2026-02-27 | Dr. Yvonne L. GreenstreetCEO & Director | 5.92k | 0.00 | Derivative Exercise and Retained Stock | - | 58.19k | 11.33% |
| 2026-02-27 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | 1.67k | 0.00 | Derivative Exercise and Retained Stock | - | 16.13k | 11.52% |
| 2026-02-27 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1.91k | 630.80k | Derivative Exercise and Sale | 328.92 - 330.73 | 5.51k | - |
| 2026-02-27 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -2.72k | 902.30k | Automatic Disposition | 330.73 - 334.39 | 5.51k | -33.06% |
| 2026-02-13 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -2.24k | 695.20k | 売り | 310.08 | 6.32k | -26.19% |
| 2026-02-13 | Dr. Yvonne L. GreenstreetCEO & Director | -6.96k | 2.16M | 売り | 310.08 | 46.35k | -13.05% |
| 2026-02-13 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1.96k | 607.45k | 売り | 310.08 | 10.17k | -16.16% |
| 2026-02-17 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -2.04k | 677.53k | Automatic Disposition | 331.96 | 10.17k | -16.72% |
| 2026-02-13 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1.96k | 607.45k | 売り | 310.08 | 12.80k | -13.28% |
| 2026-02-13 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2.24k | 695.20k | 売り | 310.08 | 37.67k | -5.62% |
| 2026-01-12 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2.78k | 1.01M | 売り | 353.95 - 377.82 | 35.34k | -7.29% |
| 2026-01-12 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1.51k | 547.93k | 売り | 353.95 - 377.82 | 3.98k | -27.50% |
| 2026-01-12 | Dr. Yvonne L. GreenstreetCEO & Director | -9.58k | 3.48M | 売り | 353.95 - 377.82 | 39.10k | -19.68% |
| 2026-01-12 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1.51k | 547.93k | 売り | 353.95 - 377.82 | 10.17k | -12.93% |
| 2026-01-13 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -2.29k | 848.06k | Automatic Disposition | 367.52 - 374.33 | 10.17k | -18.38% |
| 2026-01-12 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1.51k | 547.93k | 売り | 353.95 - 377.82 | 10.76k | -12.31% |
| 2025-11-26 | Dr. Yvonne L. GreenstreetCEO & Director | 3.58k | 345.32k | Derivative Exercise and Retained Stock | 85.00 - 119.13 | 29.67k | 13.70% |
| 2025-11-26 | Dr. Yvonne L. GreenstreetCEO & Director | -1.12k | 344.54k | Derivative Exercise and Sale | 118.05 - 445.12 | 29.67k | - |
| 2025-11-17 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -8.16k | 2.69M | Derivative Exercise and Sale | 119.13 - 449.00 | 10.17k | - |
| 2025-11-17 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -3.97k | 1.82M | Automatic Disposition | 449.00 - 463.08 | 10.17k | -28.07% |
| 2025-11-12 | Dr. Yvonne L. GreenstreetCEO & Director | -25.65k | 8.61M | Derivative Exercise and Sale | 42.22 - 458.42 | 26.09k | - |
| 2025-10-02 | Dr. Yvonne L. GreenstreetCEO & Director | -8.92k | 4.03M | 売り | 446.53 - 457.64 | 26.09k | -25.48% |
| 2025-10-02 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -3.82k | 1.73M | 売り | 446.53 - 457.64 | 31.92k | -10.69% |
| 2025-10-02 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1.41k | 635.13k | 売り | 446.53 - 457.64 | 8.47k | -14.23% |
| 2025-10-02 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -2.44k | 1.10M | 売り | 446.53 - 457.64 | 14.13k | -14.73% |
| 2025-10-02 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -2.94k | 1.33M | 売り | 446.53 - 457.64 | 1.69k | -63.48% |
| 2025-10-03 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -3.02k | 1.36M | Automatic Disposition | 449.99 - 454.37 | 1.69k | -64.13% |
| 2025-09-09 | Ms. Colleen Foley ReitanIndependent Director | -18.00k | 6.61M | Derivative Exercise and Sale | 100.65 - 480.98 | 775.00 | - |
| 2025-08-29 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -3.47k | 1.56M | Automatic Disposition | 445.53 - 452.49 | 7.02k | -33.10% |
| 2025-08-18 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1.40k | 632.76k | 売り | 447.98 - 455.82 | 1.69k | -45.24% |
| 2025-08-19 | Dr. Pushkal P. GargExec. VP & Chief Research & Development Officer | -1.46k | 666.99k | Automatic Disposition | 455.41 - 461.74 | 1.69k | -46.26% |
| 2025-08-18 | Mr. Jeffrey V. PoultonCFO & Exec. VP | -2.27k | 1.03M | 売り | 447.98 - 455.82 | 27.99k | -7.51% |
| 2025-08-18 | Mr. Tolga TangulerExec. VP & Chief Commercial Officer | -1.40k | 632.76k | 売り | 447.98 - 455.82 | 10.50k | -11.74% |
| 2025-08-18 | Dr. Kevin Joseph FitzgeraldExec. VP, Chief Scientific Officer and Head of Early Research & Early Development | -1.40k | 632.76k | 売り | 447.98 - 455.82 | 11.62k | -10.72% |
| 2025-08-18 | Dr. Yvonne L. GreenstreetCEO & Director | -6.98k | 3.16M | 売り | 447.98 - 455.82 | 22.83k | -23.41% |
| 2025-08-18 | Mr. Michael Weston Bonneyインサイダー | -11.25k | 4.27M | Derivative Exercise and Sale | 70.20 - 450.00 | 20.03k | - |
| 2025-08-14 | Dr. Dennis Arthur AusielloMember of the Scientific Advisory Board & Independent Director | -31.45k | 9.60M | Derivative Exercise and Sale | 72.01 - 442.66 | 3.64k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
